Catalog Number SGC0301 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Cardiac Arrest (1762); Coagulation Disorder (1779); Hemorrhage/Bleeding (1888); Weakness (2145)
|
Event Date 07/18/2018 |
Event Type
Death
|
Manufacturer Narrative
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
|
|
Event Description
|
This report is filed due for post procedure femoral vein bleed, hematoma, disseminated vascular coagulation (dic), and death.It was reported that a mitraclip procedure was performed.One mitraclip was implanted in the patient with degenerative mitral regurgitation (mr) grade 4, reducing the mr to grade 2.There were no device issues.Post-procedure, a femoral venous access site bleed was noted.The patient was too weak for surgery; however, the bleeding was controlled with a femostop device.The femostop device stopped the external bleeding.A computerized tomography scan was performed and a hematoma was noted at the access site.Post-procedure, the patient went into disseminated vascular coagulation (dic).On (b)(6) 2018, the patient had cardiopulmonary arrest and expired.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.It should be noted that the reported patient effects of death, hemorrhage, weakness, coagulopathy and cardiac arrest, as listed in the mitraclip system instructions for use (ifu) are known possible complications associated with mitraclip procedures.Based on the information reviewed, the reported weakness was due to the hemorrhage and the hemorrhage appears to be related to procedural conditions.The reported cardiac arrest and subsequent death was due to disseminated vascular coagulation (dic).However, a definitive cause for the dic (coagulopathy) cannot be determined as the account reporter is not willing to discuss the event any further.It is possible that the patients frail condition contributed to the coagulopathy; however, this cannot be confirmed.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|
|